Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
AGCO
AGCO
$7.15B
| $5.2M | ﹤0.01% |
67,300
+18,000
| +37% | +$1.38M |
|
1827
SPX Corp
SPXC
$11B
| $5.2M | ﹤0.01% |
+102,100
| New | +$4.67M |
|
1828
Byline Bancorp
BY
$1.78B
| $5.19M | ﹤0.01% |
265,000
+48,500
| +22% | +$886K |
|
1829
Republic Bancorp
RBCAA
$1.95B
| $5.18M | ﹤0.01% |
110,700
-4,600
| -4% | -$208K |
|
|
EXFO
1830
DELISTED
EXFO INC.
EXFO
| $5.18M | ﹤0.01% |
1,119,578
+7,738
| +0.7% | +$32.5K |
|
1831
CONMED
CNMD
$1.39B
| $5.18M | ﹤0.01% |
+46,281
| New | +$4.93M |
|
1832
Hurco Companies Inc
HURC
$135M
| $5.17M | ﹤0.01% |
134,782
-3,800
| -3% | -$134K |
|
1833
Farmers National Banc Corp
FMNB
$939M
| $5.17M | ﹤0.01% |
316,600
+33,000
| +12% | +$503K |
|
|
RFP
1834
DELISTED
Resolute Forest Products Inc.
RFP
| $5.17M | ﹤0.01% |
1,230,138
+178,538
| +17% | +$741K |
|
|
DERM
1835
DELISTED
Dermira, Inc.
DERM
| $5.17M | ﹤0.01% |
340,849
-484,349
| -59% | -$4.18M |
|
1836
Pixelworks
PXLW
$38.2M
| $5.15M | ﹤0.01% |
109,436
+19,692
| +22% | +$807K |
|
1837
Plains All American Pipeline
PAA
$17.3B
| $5.15M | ﹤0.01% |
279,800
+79,599
| +40% | +$1.46M |
|
|
PDCO
1838
DELISTED
Patterson Companies, Inc.
PDCO
| $5.14M | ﹤0.01% |
250,804
+134,300
| +115% | +$2.54M |
|
1839
Hawaiian Electric Industries
HE
$2.23B
| $5.12M | ﹤0.01% |
109,300
-190,900
| -64% | -$8.55M |
|
1840
Voya Financial
VOYA
$9.01B
| $5.12M | ﹤0.01% |
+83,900
| New | +$4.73M |
|
1841
Cullen/Frost Bankers
CFR
$10.3B
| $5.11M | ﹤0.01% |
52,300
-172,400
| -77% | -$16M |
|
1842
HCI Group
HCI
$2.23B
| $5.11M | ﹤0.01% |
111,919
-6,000
| -5% | -$265K |
|
1843
Q2 Holdings
QTWO
$3.8B
| $5.11M | ﹤0.01% |
63,000
-73,900
| -54% | -$5.68M |
|
1844
Flexsteel Industries
FLXS
$302M
| $5.11M | ﹤0.01% |
256,293
+29,875
| +13% | +$521K |
|
|
AJRD
1845
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $5.11M | ﹤0.01% |
111,800
-532,995
| -83% | -$24.1M |
|
|
ONC
1846
BeOne Medicines Ltd
ONC
$32.8B
| $5.08M | ﹤0.01% |
+30,619
| New | +$5.09M |
|
1847
Metropolitan Bank Holding Corp
MCB
$1.15B
| $5.07M | ﹤0.01% |
105,200
+48,417
| +85% | +$2.14M |
|
1848
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
| $5.07M | ﹤0.01% |
+55,500
| New | +$5.06M |
|
1849
RPM International
RPM
$13.7B
| $5.07M | ﹤0.01% |
66,000
-143,100
| -68% | -$10.4M |
|
1850
RF Industries
RFIL
$134M
| $5.05M | ﹤0.01% |
746,700
+25,978
| +4% | +$162K |
|
Similar funds
Renaissance Technologies's Q4 2019 Portfolio in Review
As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Renaissance Technologies fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Renaissance Technologies opened 518 new positions and closed 443 in Q4 2019.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.